Veena Shankaran
Overview
Explore the profile of Veena Shankaran including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
78
Citations
3992
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ko A, Chao J, Noel M, Shankaran V, Sohal D, Crow M, et al.
Cancer Res Commun
. 2025 Feb;
5(2):349-357.
PMID: 39907035
Purpose: Neoadjuvant chemoradiation (NCRT) followed by surgical resection represents a standard approach for patients with locally advanced esophageal/gastroesophageal junction (GEJ) cancers. Sotigalimab is a high-affinity CD40 agonist antibody capable of...
2.
Wheeler S, Thom B, Waters A, Shankaran V
JCO Oncol Pract
. 2025 Jan;
21(1):29-40.
PMID: 39793544
Purpose: As oncology practices implement routine screening for financial hardship (FH) and health-related social needs, interventions that address these needs must be implemented. A growing body of literature has reported...
3.
Kwendakwema C, Hopkins T, Bell-Brown A, Simianu V, Shankaran V, Issaka R
Cancer Med
. 2024 Sep;
13(18):e70244.
PMID: 39315598
Introduction: Colorectal cancer (CRC) is the second leading cause of cancer deaths in the United States. Surveillance colonoscopy is recommended 1-year after surgical resection for patients with stage I-III CRC;...
4.
Jones S, Yi J, Henrikson N, Panattoni L, Shankaran V
Future Sci OA
. 2024 Jun;
10(1):FSO983.
PMID: 38827796
This qualitative study refined a conceptual model of financial hardship and developed measures corresponding to model constructs. Eighteen women with breast cancer recruited through a comprehensive cancer center completed interviews....
5.
Banerjee R, Cowan A, Ortega M, Missimer C, Carpenter P, Ueda Oshima M, et al.
Clin Lymphoma Myeloma Leuk
. 2024 Mar;
24(7):446-454.e3.
PMID: 38521640
Background: Patients with multiple myeloma (MM) may be on therapy for years, which can lead to financial toxicity (FinTox) or time toxicity (TimeTox). The prevalence, predictors, and quality of life...
6.
Bell-Brown A, Hopkins T, Watabayashi K, Overstreet K, Leahy A, Bradshaw E, et al.
Support Care Cancer
. 2024 Feb;
32(3):189.
PMID: 38400905
Purpose: Many cancer patients and caregivers experience financial hardship, leading to poor outcomes. Gastric and gastroesophageal junction (GEJ) cancer patients are particularly at risk for financial hardship given the intensity...
7.
Warren J, Mariotto A, Stevens J, Davidoff A, Shankaran V, Ward K, et al.
J Clin Oncol
. 2024 Feb;
42(9):1001-1010.
PMID: 38320222
Purpose: This study assessed the prevalence of specific major adverse financial events (AFEs)-bankruptcies, liens, and evictions-before a cancer diagnosis and their association with later-stage cancer at diagnosis. Methods: Patients age...
8.
Rodriguez P, Heagerty P, Clark S, Khor S, Chen Y, Haupt E, et al.
JCO Clin Cancer Inform
. 2023 Nov;
7:e2300066.
PMID: 37963310
Purpose: The risk of colorectal cancer (CRC) recurrence after primary treatment varies across individuals and over time. Using patients' most up-to-date information, including carcinoembryonic antigen (CEA) biomarker profiles, to predict...
9.
10.
Bell-Brown A, Watabayashi K, Delaney D, Carlos R, Langer S, Unger J, et al.
JNCI Cancer Spectr
. 2023 Aug;
7(5).
PMID: 37561111
Background: Cancer-related financial hardship is a side effect of cancer diagnosis and treatment, and affects both patients and caregivers. Although many oncology clinics have increased financial navigation services, few have...